Loading…
NewcelX Ltd. is projected to rise to $5.54 by 2027, a +61% move from its current price of $3.45. NCEL is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.24 | $3.45 | $3.68 | +0.05% |
| May 30 | $3.15 | $3.45 | $3.78 | +0.11% |
| May 31 | $3.09 | $3.46 | $3.86 | +0.16% |
| Jun 1 | $3.04 | $3.46 | $3.93 | +0.21% |
| Jun 2 | $3.00 | $3.46 | $3.99 | +0.27% |
| Jun 3 | $2.96 | $3.46 | $4.05 | +0.32% |
| Jun 4 | $2.92 | $3.46 | $4.10 | +0.37% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.92 | $3.46 | $4.10 | +0.37% |
| Week 2 | $2.73 | $3.48 | $4.42 | +0.75% |
| Week 3 | $2.60 | $3.49 | $4.68 | +1.13% |
| Week 4 | $2.49 | $3.50 | $4.92 | +1.51% |
| Week 5 | $2.41 | $3.52 | $5.14 | +1.89% |
| Week 6 | $2.33 | $3.53 | $5.35 | +2.27% |
| Week 7 | $2.26 | $3.54 | $5.55 | +2.65% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NewcelX Ltd. is a biotechnology company in Healthcare that develops transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.
The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Its stock symbol is NCEL.
NewcelX Ltd. (NCEL) is currently trading at $3.45 per share.
The company has a market cap of $18.57M and is ranked 4922.
The forecast landscape shows an overall price outlook with a long-horizon bullish tilt, featuring rising averages into the late 2020s and beyond. For example, the year-by-year averages start at $3.45 in 2026 and rise to $5.67 in 2030, $11.23 in 2040, and $14.23 in 2050.
A major floor 65.3% below — a decisive break under it would weaken the trend.
The nearest floor, 27.8% below — buyers have tended to step in here.
The nearest ceiling, 42.3% above — a clean break opens room to run.
A major ceiling 75.0% above — clearing it would confirm fresh momentum.
Key NCEL support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NCEL market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.24 | Buy | $3.27 | Buy |
| MA 10 | $3.24 | Buy | $3.27 | Buy |
| MA 20 | $3.40 | Buy | $3.29 | Buy |
| MA 50 | $2.98 | Buy | $3.18 | Buy |
| MA 100 | $2.81 | Buy | $3.98 | Sell |
| MA 200 | $7.91 | Sell | $8.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 54.27 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 15.52 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | 2.68 | Buy |
| Bollinger %B (20,2) | 0.54 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.34 | Buy |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 62.98 | Neutral |
| Momentum (10) | 0.12 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 3.24 | Buy |
| ADX (14) | 9.67 | Neutral |
| ATR (14) | 0.18 | Info |
The 30-day technical picture is neutral, with RSI(14) at 50.
The stock’s SMA50 is $2.98 and SMA200 is $7.91, framing near-term support and longer-term resistance levels. The key support is listed at $2.49 and resistance at $4.91.
Over the next 30 days, the price has traded within a range of $2.26 to $5.27.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.88 | $3.45 | $5.32 | 0% | Neutral | |
| $3.99 | $5.54 | $8.33 | +61% | Bullish | |
| $3.74 | $5.51 | $8.81 | +60% | Bullish | |
| $3.38 | $5.25 | $8.80 | +52% | Bullish | |
| $3.49 | $5.67 | $9.89 | +64% | Bullish | |
| $2.57 | $4.36 | $7.87 | +26% | Bullish | |
| $2.89 | $5.12 | $9.53 | +49% | Bullish | |
| $4.31 | $7.95 | $15.19 | +130% | Bullish | |
| $4.07 | $7.81 | $15.29 | +126% | Bullish | |
| $3.99 | $7.96 | $15.93 | +131% | Bullish | |
| $5.05 | $11.23 | $24.70 | +225% | Bullish | |
| $6.40 | $14.23 | $32.72 | +312% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.88 | $3.45 | $4.13 | +0.00% |
| June 2026 | $3.09 | $3.71 | $4.61 | +7.48% |
| July 2026 | $2.97 | $3.62 | $4.62 | -2.32% |
| August 2026 | $2.87 | $3.55 | $4.61 | -2.05% |
| September 2026 | $3.10 | $3.87 | $5.11 | +9.19% |
| October 2026 | $3.22 | $4.07 | $5.45 | +5.04% |
| November 2026 | $3.04 | $3.87 | $5.24 | -4.89% |
| December 2026 | $3.02 | $3.89 | $5.32 | +0.42% |
Click any year to see its month-by-month NCEL forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect NCEL to range from $1.88 to $5.32 through 2026. The $3.45 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The NCEL price prediction for 2027 points to an average of $5.54 (low $3.99, high $8.33) — a potential gain of +61% on today's $3.45. Momentum favours further upside here.
In 2028, NCEL is projected to trade between $3.74 and $8.81, averaging $5.51 — a potential gain of +60% from today's $3.45. That is -1% versus the projected 2027 average. Buyers look set to stay in control over this stretch.
NewcelX Ltd.'s 2029 outlook centres on $5.25, within a $3.38 to $8.80 range. That is -5% versus the projected 2028 average. That marks a +52% change versus current levels. Momentum favours further upside here.
By 2030, NCEL could reach as high as $9.89, with a base case around $5.67 and support toward $3.49 — roughly +64% from $3.45. Buyers look set to stay in control over this stretch.
Expect NCEL to range from $2.57 to $7.87 through 2031. The $4.36 average target implies a +26% move from current prices. That is -23% versus the projected 2030 average. Momentum favours further upside here.
The NCEL price prediction for 2032 points to an average of $5.12 (low $2.89, high $9.53) — a potential gain of +49% on today's $3.45. Buyers look set to stay in control over this stretch.
In 2033, NCEL is projected to trade between $4.31 and $15.19, averaging $7.95 — a potential gain of +130% from today's $3.45. That is up +55% on the projected 2032 average. Momentum favours further upside here.
NewcelX Ltd.'s 2034 outlook centres on $7.81, within a $4.07 to $15.29 range. That is -2% versus the projected 2033 average. That marks a +126% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, NCEL could reach as high as $15.93, with a base case around $7.96 and support toward $3.99 — roughly +131% from $3.45. Momentum favours further upside here.
Expect NCEL to range from $5.05 to $24.70 through 2040. The $11.23 average target implies a +225% move from current prices. That is up +41% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The NCEL price prediction for 2050 points to an average of $14.23 (low $6.40, high $32.72) — a potential gain of +312% on today's $3.45. Momentum favours further upside here.
Investing $1,000 in NCEL today (≈ 289.855072 NCEL) could be worth
$4,123.84
+$3,123.84 (+312%) by 2050 · US Dollar
Based on the average projected NCEL price of $14.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NCELwould be worth at today's price.
$1,000 invested in NCEL on May 27, 2025 (≈ 48.076925 NCEL) would be worth
$165.87
-$834.13 (-83.4%) today · 0.17× · US Dollar
Based on a NCEL entry price of $20.8 vs. today's $3.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.25 | $1,061.54 | +6.2% |
| 1 month ago | $3.87 | $891.47 | -10.9% |
| 3 months ago | $2.87 | $1,202.09 | +20.2% |
| 6 months ago | $4.01 | $860.35 | -14.0% |
| 1 year ago | $20.8 | $165.87 | -83.4% |
| All time (5.0y) ago | $1,344 | $2.57 | -99.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NCEL forecast.
Our base-case forecast reaches $6.90 around 2033.
Implied market cap at $6.90: $37.15M
The multi-year outlook is bullish overall, with yearly forecast sentiment labeled BULLISH in most years and a mid-year neutral in 2026. The 2030 forecast shows an average price of $5.67 with a 64.5% ROI. The 2040 forecast shows an average of $11.23 with a 225.4% ROI, and the 2050 forecast shows an average of $14.23 with a 312.4% ROI.
These figures imply meaningful upside potential, but they are estimates and not guarantees. The path will depend on market dynamics, execution, and external factors that influence biotechnology equities.
Tap a question to reveal the answer.
Avg $5.67; min $3.49; max $9.89; ROI 64.5; sentiment BULLISH.
Forecasts show a bullish trajectory in multiple years with averages rising to $14.23 by 2050 and ROI up to 312.4%, though 2026 is neutral; these are estimates and not guarantees.
Yes, the forecast max is $24.70 in 2040 and $32.72 in 2050, indicating $20 is within the predicted range, but not guaranteed.
Current price is $3.45 and market cap is $18.57M.
Low $2.26, High $5.27.
NewcelX Ltd. Community Discussion
0Share your NewcelX Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.